Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
|
|
MERRIMACK PHARMACEUTICALS INC (MACK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2019 |
8-K
| Quarterly results |
| 11/07/2018 |
8-K
| Quarterly results |
| 08/07/2018 |
8-K
| Quarterly results |
| 05/08/2018 |
8-K
| Quarterly results |
| 11/08/2017 |
8-K
| Quarterly results |
| 08/09/2017 |
8-K
| Quarterly results |
| 05/10/2017 |
8-K
| Form 8-K - Current report |
| 11/09/2016 |
8-K
| Quarterly results |
| 05/02/2016 |
8-K
| Form 8-K - Current report |
| 02/25/2016 |
8-K
| Quarterly results |
| 11/09/2015 |
8-K
| Quarterly results |
| 08/10/2015 |
8-K
| Quarterly results|
Docs:
|
"Merrimack Pharmaceuticals Reports Second Quarter 2015 Financial Results CAMBRIDGE, Mass., Aug. 10, 2015 - Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its second quarter 2015 financial results. Merrimack will host a live conference call and webcast today, Monday, August 10 at 4:30 p.m., Eastern time, to provide an update on Merrimack's progress as well as a summary of these results. Investors and the general public are invited to listen to the call by dialing 564-1301 or 357-2394 five minutes prior to the start of the call and providing the passcode 97495685. A listen-only webcast of the call can be accessed in the Inves..." |
|
| 05/07/2015 |
8-K
| Quarterly results|
Docs:
|
"Merrimack Pharmaceuticals Reports First Quarter 2015 Financial Results CAMBRIDGE, Mass., May 7, 2015 - Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its first quarter 2015 financial results. Merrimack will host a live conference call and webcast today, Thursday, May 7 at 4:30 p.m., Eastern time, to provide an update on Merrimack's progress as well as a summary of these results. Investors and the general public are invited to listen to the call by dialing 564-1301 or 357-2394 five minutes prior to the start of the call and providing the passcode 34571198. A listen-only webcast of the call can be accessed in the Investors s..." |
|
| 02/26/2015 |
8-K
| Quarterly results|
Docs:
|
"Merrimack Pharmaceuticals Reports Fourth Quarter 2014 Financial Results CAMBRIDGE, Mass., February 26, 2015 - Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its fourth quarter and full year 2014 financial results. Merrimack will host a live conference call and webcast today, Thursday, February 26 at 8:30 a.m., Eastern time, to provide an update on Merrimack's progress as well as a summary of these results. Investors and the general public are invited to listen to the call by dialing 564-1301 or 357-2394 five minutes prior to the start of the call and providing the passcode 83858396. Presentation slides and a listen-only we..." |
|
| 11/10/2014 |
8-K
| Quarterly results|
Docs:
|
"Merrimack Pharmaceuticals Reports Third Quarter 2014 Financial Results CAMBRIDGE, Mass., November 10, 2014 - Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its third quarter 2014 financial results. Merrimack will host a live conference call and webcast today, Monday, November 10 at 4:30 p.m., Eastern Time, to provide an update on Merrimack's progress as well as a summary of these results. Investors and the general public are invited to listen to the call by dialing 564-1301 or 357-2394 five minutes prior to the start of the call and providing the passcode 28850166. A listen-only webcast of the call can be accessed in the I..." |
|
| 08/11/2014 |
8-K
| Quarterly results|
Docs:
|
"Merrimack Pharmaceuticals Reports Second Quarter 2014 Financial Results CAMBRIDGE, Mass., August 11, 2014 - Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its second quarter 2014 financial results. Merrimack will host a live conference call and webcast today, Monday, August 11 at 8:00 a.m., Eastern Time, to provide an update on Merrimack's progress as well as a summary of second quarter 2014 financial results. Investors and the general public are invited to listen to the call by dialing 564-1301 or 357-2394 five minutes prior to the start of the call and providing the passcode 83151516. Slides and a listen-only webcast of ..." |
|
| 05/01/2014 |
8-K
| Quarterly results|
Docs:
|
"Merrimack Pharmaceuticals Reports First Quarter 2014 Financial Results CAMBRIDGE, Mass., May. 1, 2014 - Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its first quarter 2014 financial results. Merrimack will host a live conference call and webcast today, Thursday, May 1 at 8:30 a.m., Eastern Time, to provide a summary of first quarter 2014 financial results as well as discuss the positive top line results of the combination arm of MM-398's Phase 3 NAPOLI-1study in post-gemcitabine metastatic pancreatic cancer announced this morning. Investors and the general public are invited to listen to the call by dialing 564-1301 or 3...",
"Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic Pancreatic Cancer" |
|
| 11/07/2013 |
8-K
| Form 8-K - Current report |
| 08/08/2013 |
8-K
| Form 8-K - Current report |
| 05/13/2013 |
8-K
| Quarterly results |
| 11/14/2012 |
8-K
| Form 8-K - Current report |
| 08/10/2012 |
8-K
| Form 8-K - Current report |
| 05/15/2012 |
8-K
| Form 8-K - Current report |
|
|